Published January 24, 2019 | Version v1
Dataset Open

Testing Hit Analogues against USP5 Zf-UBD with SPR Assay #1

Creators

  • 1. University of Toronto, Structural Genomics Consortium

Description

A surface plasmon resonance (SPR) assay is used to determine binding affinities of commercial compound analogues previously selected to explore the structure activity relationship (SAR) around our primary hits against the zinc finger ubiquitin binding domain (Zf-UBD) of USP5.

Notes

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

1_SPR_20190124.pdf

Files (54.4 MB)

Name Size Download all
md5:6557de9a5227b80a111503901d4c92d6
733.7 kB Preview Download
md5:c9e06ef013b958a3d6ee4ccdb5ef2f2d
24.5 MB Download
md5:358363d2090b8955167483d635b2114c
29.1 MB Download